Biogen Idec Inc.

NAS : BIIB
Pharmaceuticals
Weston Massachusetts
2011 Revenue (US$ Millions)$4,052
2010 Revenue (US$ Millions)$3,639
Revenue Growth (%)11.34%
Net Income (US$ Millions)$1,234
Common Shares Outstanding (Millions)$242
Earnings Per Share (US$)$5.04
Earnings Per Share Growth (%)27.92%
Price To Earnings Ratio23.32
Total Equity (US$ Millions)$6,426
Profit Growth (%)22.8
Profit Margin (%)30.46%
Return On Equity (%)22.87%
Long Term Debt (US$ Millions)$1,061
Debt To Equity Ratio (%)0.17%
Market Capitalization (US$ Millions)$26,645
Total Assets (US$ Millions)$9,050
Return on Assets (%)15.25
Current Assets (US$ Millions)$2,975
Inventories (US$ Millions)$327
Current Liabilities (US$ Millions)$913
Cost of Goods Sold (US$ Millions)$467
Asset Turnover0.45
Inventory Turnover1.52